WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Synaptic Systems Antibody Company
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (73)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newton, S. S.
Right arrow Articles by Duman, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newton, S. S.
Right arrow Articles by Duman, R. S.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Depression
Hazardous Substances DB
*NALTREXONE

 Previous Article  |  Next Article 

The Journal of Neuroscience, December 15, 2002, 22(24):10883-10890

Inhibition of cAMP Response Element-Binding Protein or Dynorphin in the Nucleus Accumbens Produces an Antidepressant-Like Effect

Samuel S. Newton1, Johannes Thome1, Tanya L. Wallace1, Yukihikko Shirayama1, Lee Schlesinger1, Norio Sakai1, Jingshan Chen1, Rachael Neve2, Eric J. Nestler3, and Ronald S. Duman1

1 Division of Molecular Psychiatry, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Yale University School of Medicine, New Haven, Connecticut 06508, 2 McLean Hospital, Harvard University, Belmont, Massachusetts 02478, and 3 Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, Texas 75390

The cAMP response element-binding protein (CREB) is a critical integrator of neural plasticity that is responsive in a brain region-specific manner to a variety of environmental and pharmacological stimuli, including widely prescribed antidepressant medications. We developed inducible transgenic lines of mice that express either CREB or a dominant-negative mutant of CREB (mCREB) in forebrain regions and used these mice to determine the functional significance of this transcription factor in the learned helplessness paradigm, a behavioral model of depression. We also use a complementary viral-mediated gene transfer approach to directly test the effect of mCREB in the nucleus accumbens, a brain region important for motivation and reward. The results demonstrate that blockade of CREB by overexpression of mCREB in transgenic mice or by viral expression of mCREB in the nucleus accumbens produces an antidepressant-like effect, whereas overexpression of CREB in transgenic mice results in the opposite phenotype. In addition, mCREB expression was colocalized with and decreased the expression of prodynorphin in nucleus accumbens medium spiny neurons, and antagonism of dynorphin in the nucleus accumbens was sufficient to produce an antidepressant-like effect similar to that observed after blockade of CREB. Together, the results demonstrate that nucleus accumbens CREB-dynorphin influence behavior in the learned helplessness model and suggest that this signaling cascade may contribute to symptoms of depression.

Key words: learned helplessness; dysphoria; depression; prodynorphin; kappa -opiate receptors; behavior


Copyright © 2002 Society for Neuroscience  0270-6474/02/222410883-08$05.00/0


This article has been cited by other articles:


Home page
Cereb CortexHome page
Y. Lin, C. Westenbroek, P. Bakker, J. Termeer, A. Liu, X. Li, and G. J. Ter Horst
Effects of Long-Term Stress and Recovery on the Prefrontal Cortex and Dentate Gyrus in Male and Female Rats
Cereb Cortex, March 20, 2008; (2008) bhn035v1.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. V. Carr and S. D. Mague
p38: The Link between the {kappa}-Opioid Receptor and Dysphoria
J. Neurosci., March 5, 2008; 28(10): 2299 - 2300.
[Full Text] [PDF]


Home page
J. Neurosci.Home page
T. A. Green, I. N. Alibhai, S. Unterberg, R. L. Neve, S. Ghose, C. A. Tamminga, and E. J. Nestler
Induction of Activating Transcription Factors (ATFs) ATF2, ATF3, and ATF4 in the Nucleus Accumbens and Their Regulation of Emotional Behavior
J. Neurosci., February 27, 2008; 28(9): 2025 - 2032.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
J. A. Trafton and E. V. Gifford
Behavioral Reactivity and Addiction: The Adaptation of Behavioral Response to Reward Opportunities
J Neuropsychiatry Clin Neurosci, February 1, 2008; 20(1): 23 - 35.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. R. Bruchas, B. B. Land, M. Aita, M. Xu, S. K. Barot, S. Li, and C. Chavkin
Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates {kappa}-Opioid-Dependent Dysphoria
J. Neurosci., October 24, 2007; 27(43): 11614 - 11623.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. L. Gur, A. C. Conti, J. Holden, A. J. Bechtholt, T. E. Hill, I. Lucki, J. E. Malberg, and J. A. Blendy
cAMP Response Element-Binding Protein Deficiency Allows for Increased Neurogenesis and a Rapid Onset of Antidepressant Response
J. Neurosci., July 18, 2007; 27(29): 7860 - 7868.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. J. Will, W. M. Vanderheyden, and A. E. Kelley
Striatal opioid peptide gene expression differentially tracks short-term satiety but does not vary with negative energy balance in a manner opposite to hypothalamic NPY
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R217 - R226.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. A. Green, I. N. Alibhai, J. D. Hommel, R. J. DiLeone, A. Kumar, D. E. Theobald, R. L. Neve, and E. J. Nestler
Induction of inducible cAMP early repressor expression in nucleus accumbens by stress or amphetamine increases behavioral responses to emotional stimuli.
J. Neurosci., August 9, 2006; 26(32): 8235 - 8242.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
D. Tardito, J. Perez, E. Tiraboschi, L. Musazzi, G. Racagni, and M. Popoli
Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview.
Pharmacol. Rev., March 1, 2006; 58(1): 115 - 134.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. A. Carlezon Jr., C. Beguin, J. A. DiNieri, M. H. Baumann, M. R. Richards, M. S. Todtenkopf, R. B. Rothman, Z. Ma, D. Y.-W. Lee, and B. M. Cohen
Depressive-Like Effects of the {kappa}-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 440 - 447.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Barrot, D. L. Wallace, C. A. Bolanos, D. L. Graham, L. I. Perrotti, R. L. Neve, H. Chambliss, J. C. Yin, and E. J. Nestler
Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens
PNAS, June 7, 2005; 102(23): 8357 - 8362.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Chaki, T. Funakoshi, S. Hirota-Okuno, M. Nishiguchi, T. Shimazaki, M. Iijima, A. J. Grottick, K. Kanuma, K. Omodera, Y. Sekiguchi, et al.
Anxiolytic- and Antidepressant-Like Profile of ATC0065 and ATC0175: Nonpeptidic and Orally Active Melanin-Concentrating Hormone Receptor 1 Antagonists
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 831 - 839.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Einat, P. Yuan, T. D. Gould, J. Li, J. Du, L. Zhang, H. K. Manji, and G. Chen
The Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation
J. Neurosci., August 13, 2003; 23(19): 7311 - 7316.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. D. Mague, A. M. Pliakas, M. S. Todtenkopf, H. C. Tomasiewicz, Y. Zhang, W. C. Stevens Jr., R. M. Jones, P. S. Portoghese, and W. A. Carlezon Jr.
Antidepressant-Like Effects of kappa -Opioid Receptor Antagonists in the Forced Swim Test in Rats
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 323 - 330.
[Abstract] [Full Text]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-